http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106086182-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106086182-B |
| titleOfInvention | PCYOX1 albumen is as the application in cerebral arterial thrombosis biomarker |
| abstract | The invention discloses PCYOX1 albumen as the application in cerebral arterial thrombosis biomarker.It specifically discloses PCYOX1 albumen or its active fragment or detects application of the substance of PCYOX1 albumen or its active fragment in the product that diagnosing ischemia cerebral apoplexy and/or assessment suffer from ischemic cerebral apoplexy risk.The invention discloses a kind of albumen PCYOX1s relevant to cerebral apoplexy, and further confirm that the PCYOX1 albumen or its active fragment express downward in cerebral apoplexy tissue.It can not only quickly and effectively accomplish early detection using the Protein Detection cerebral apoplexy, and provide therapy target and important evidence for clinical applications such as gene therapy, drug therapies. |
| priorityDate | 2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.